A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists

Chemistry and Biology

Volumn 12, Issue 2, 2005, Pages 237-247

  Jacobson, Kenneth A ^a   Ohno, Michihiro ^a   Duong, Heng T ^a   Kim, Soo Kyung ^a   Tchilibon, Susanna ^a   Česnek, Michal ^b   Holý, Antonín ^b   Gao, Zhan Guo ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 14144249916     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.12.010     Document Type: Article

References (40)

1. B.B. Fredholm, A.P. IJzerman, K.A. Jacobson, K-N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol. Rev. 53 2001 527 552
2. 1 agonists with diminished hypotensive effects J. Med. Chem. 42 1999 3463 3477
3. D.K.J.E. von Lubitz, R.-C. Lin, I.A. Paul, M. Beenhakker, M. Boyd, N. Bischofberger, and K.A. Jacobson Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils Eur. J. Pharmacol. 316 1996 171 179
4. 2A adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion Am. J. Physiol. Renal Physiol. 279 2000 F809 F818
5. A. Ohta, and M. Sitkovsky Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage Nature 414 2001 916 920
6. 2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia J. Vasc. Surg. 35 2002 994 998
7. 1-selective agonists J. Pharm. Pharmacol. 83 1994 46 53
8. 1 receptor agonist Pharm. Res. 18 2001 531 536
9. 3 receptor with selectively enhanced affinity for amine-modified nucleosides J. Med. Chem. 44 2001 4125 4136
10. 2A agonist and antagonist J. Med. Chem. 46 2003 4847 4859
11. M. Parsons, L. Young, J.-E. Lee, K.A. Jacobson, and B.T. Liang Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D FASEB J. 14 2000 1423 1431
12. M. Ohno, Z.G. Gao, P. Van Rompaey, S. Tchilibon, S.-K. Kim, B.A. Harris, J. Blaustein, A.S. Gross, H.T. Duong, and S. Van Calenbergh Modulation of adenosine receptor affinity and intrinsic efficacy in nucleosides substituted at the 2-position Bioorg. Med. Chem. 12 2004 2995 3007
13. M. Hocek Syntheses of purines bearing carbon substituents in positions 2, 6 or 8 by metal- or organometal-mediated C C bond-forming reactions Eur. J. Org. Chem. 2003 245 254
14. 3 adenosine receptors Biochem. Pharmacol. 65 2003 1675 1684
15. P. Coward, H.G. Wada, M.S. Falk, S.D. Chan, F. Meng, H. Akil, and B.R. Conklin Controlling signaling with a specifically designed Gi-coupled receptor Proc. Natl. Acad. Sci. USA 95 1998 352 357
16. Y. Liu, K. Shah, F. Yang, L. Witucki, and K.M. Shokat Engineering Src family protein kinases with unnatural nucleotide specificity Chem. Biol. 5 1998 91 101
17. P.J. Belshaw, and S.L. Schreiber Cell-specific calcineurin inhibition by a modifed cyclosporin J. Am. Chem. Soc. 119 1997 1805 1806
18. R. Tedesco, J.A. Thomas, B.S. Katzenellenbogen, and J.A. Katzenellenbogen The estrogen receptor: a structure-based approach to the design of new specific hormone-receptor combinations Chem. Biol. 8 2001 277 287
19. J.T. Koh Designing selectivity and discrimination into re-engineered ligand-receptor interfaces; beyond bumps and holes Chem. Biol. 9 2002 17 23
20. C.M. Niswender, R.W. Ishihara, L.M. Judge, C. Zhang, K.M. Shokat, and G.S. McKnight Protein engineering of protein kinase A catalytic subunits results in the acquisition of novel inhibitor sensitivity J. Biol. Chem. 277 2002 28916 28922
21. R. Wildbrandt, U. Frotscher, M. Freyland, W. Messerschmidt, R. Richter, M. Schulte-Lippern, and B. Zschaege Treatment of glomerulonephritis with metrifudil. Preliminary report Med. Klin. (Munich) 67 1972 1138 1140
22. 3-selective adenosine agonists J. Med. Chem. 37 1994 636 646
23. J. Žemlička, and F. Šorm The reaction of dimethylchloromethylene ammonium chloride with 2′,3′,5′-tri-O- acetylinosine: a new synthesis of 6-chloro-9-(beta-D-ribofuranosyl)purine Collect. Czech. Chem. Commun. 30 1965 1880 1885
24. F. Kappler, and A. Hampton Approaches to isozyme-specific inhibitors. 17. Attachment of a selectivity-inducing substituent to a multisubstrate adduct. Implications for facilitated design of potent, isozyme-selective inhibitors J. Med. Chem. 33 1990 2545 2551
25. 1 conformationally restricted adenosines Bioorg. Med. Chem. Lett. 8 1998 695 698
26. K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, H. Motoshima, B.A. Fox, I. Le Trong, D.C. Teller, T. Okada, and T.E. Stenkamp Crystal structure of rhodopsin: a G protein-coupled receptor Science 289 2000 739 745
27. 2A-adenosine receptors and the biogenic amine family J. Med. Chem. 40 1997 2588 2595
28. 2A adenosine receptors: involvement of Glu13 and His278 in ligand binding and sodium modulation Biochem Pharmacol. 60 2000 661 668
29. C. Nordstedt, and B.B. Fredholm A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid Anal. Biochem. 189 1990 231 234
30. 2B ligand J. Med. Chem. 45 2002 3271 3279
31. 4 receptors in heart failure: rescue of the calsequestrin-overexpression model of cardiomyopathy Am. J. Physiol. Heart Circ. Physiol. 287 2004 1096 1103
32. A.D. Brooks, B. Ng, D. Liu, M. Brownlee, M. Burt, H.J. Federoff, and Y. Fong Specific organ gene transfer in vivo by regional organ perfusion with herpes viral amplicon vectors: implications for local gene therapy Surgery 129 2001 324 334
33. A.J. Slavin, I.H. Tarner, A. Nakajima, I. Urbanek-Ruiz, J. McBride, C.H. Contag, and C.G. Fathman Adoptive cellular gene therapy of autoimmune disease Autoimmun. Rev. 1 2002 213 219
34. SYBYL Molecular Modeling System, version 6.9 (computer program). Tripos Inc., St. Louis, Missouri.
35. T.A. Halgren MMFF VII. Characterization of MMFF94, MMFF94s, and other widely available force fields for conformational energies and for intermolecular-interaction energies and geometries J. Comput. Chem. 20 1999 730 748
36. J.J.P. Stewart MOPAC: a semiempirical molecular orbital program J. Comput. Aided Mol. Des. 4 1990 1 105
37. J.P. Ryckaert, G. Ciccotti, and H.J.C. Berendsen Numerical integration of the Cartesian equations of motion for a system with constraints: molecular dynamics of n-alkanes J. Comput. Phys. 23 1977 327 341
38. W.D. Cornell, P. Cieplak, C.I. Bayly, I.R. Gould, K.M. Merz Jr., D.M. Ferguson, D.C. Spellmeyer, T. Fox, J.W. Caldwell, and P.A. Kollman A second generation force field for the simulation of proteins, nucleic acids and organic molecules J. Am. Chem. Soc. 117 1995 5179 5197
39. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
40. Y-C. Cheng, and W.H. Prusoff Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22 1973 3099 3108